Patents
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
11/2013
11/05/2013US8575342 HIV inhibiting 5-heterocyclyl pyrimidines
11/05/2013US8575339 Derivatives of erlotinib
11/05/2013US8575338 Pyrimidine, pyridine and triazine derivatives as maxi-K channel openers
11/05/2013US8575187 Combinations of anilinopyrimidines and pyrion compounds
11/05/2013US8575184 Quinazolines as potassium ion channel inhibitors
11/05/2013US8575183 Heterocyclic compounds and their uses
11/05/2013US8575168 Compounds and compositions as modulators of GPR119 activity
11/05/2013US8575163 Pyrrolopyridinylpyrimidin-2-ylamine derivatives
11/05/2013US8575153 Pyridine-3-carboxyamide derivative
11/05/2013US8575143 3-aryl-substituted quinazolones, and uses thereof
11/05/2013CA2609050C Method for production of 1-alkyl-3-phenyluracils
11/05/2013CA2594345C Compositions and methods of treating cell proliferation disorders
11/05/2013CA2593578C Cxcr4 antagonists for the treatment of medical disorders
10/2013
10/31/2013WO2013163190A1 Dna-pk inhibitors
10/31/2013WO2013161993A1 Trans-2-decenoic acid derivative and drug containing same
10/31/2013WO2013161904A1 Sulfonamide derivative and medicinal use thereof
10/31/2013WO2013161853A1 Quinazolinedione derivative
10/31/2013WO2013160418A1 Novel compounds
10/31/2013WO2013159286A1 Etravirine and method for preparing intermediate thereof
10/31/2013WO2013159224A1 2-carbamo(thio)yl-1,3- dioxopropyl derivatives in cancer therapy
10/31/2013US20130289280 Novel pharmaceutical forms, and methods of making and using the same
10/31/2013US20130289044 Quinazoline Compounds as Sodium Channel Blockers
10/30/2013EP2657229A1 Benzyloxypyrimidine derivative, agricultural/horticultural insecticide comprising derivative and method for using same
10/30/2013EP2655398A2 Efficient peptide couplings and their use in the synthesis and isolation of a cyclopenta (g) quinazoline trisodium salt
10/30/2013EP2655375A1 Pyrimidinone derivatives, preparation thereof and pharmaceutical use thereof
10/30/2013EP2655341A2 Novel processes for preparing triazolo[4,5-d]pyrimidine derivatives and intermediates thereof
10/30/2013EP2655340A1 Bi-heteroaryl compounds as vps34 inhibitors
10/30/2013EP2655339A1 Electronic device including a pyrimidine compound
10/30/2013EP2655331A1 Glucagon receptor modulators
10/30/2013CN103373971A Urea compounds serving as protein kinase inhibitors
10/30/2013CN103373966A 4-anilino quinazoline amido derivatives as well as preparation methods and applications thereof
10/30/2013CN103373965A Preparation methods of etravirine and intermediate body thereof
10/30/2013CN103373964A Method for synthesizing 2-amido-4-p-methoxyphenyl-5-cyan-1,6-dihydropyrimidine-6-ketone
10/30/2013CN102036667B Compositions comprising quinazoline derivatives, preparation methods and uses thereof
10/30/2013CN101668423B 2-aminopyrimidine modulators of histamine h4 receptor
10/30/2013CN101511805B Carbonylated (aza) cyclohexanes as dopamine D3 receptor ligands
10/29/2013US8569543 CCR9 inhibitors and methods of use thereof
10/29/2013US8569492 Method for preparing halofuginone derivative
10/29/2013US8569478 Modified 4′-nucleosides as antiviral agents
10/29/2013US8569322 Lamivudine oxalate and preparation method thereof
10/29/2013US8569318 Tetrahydro-pyrazolo[1,5-a]pyrido-pyrimidines as antagonists of serotonin 5-HT6 receptors, methods for the production and use thereof
10/29/2013US8569317 Aryl-quinazoline/aryl-2amino-phenyl methanone derivatives
10/29/2013US8569310 Pentafluorosulfur imino heterocyclic compounds as BACE-1 inhibitors, compositions and their use
10/29/2013US8569302 Inhibitors of flaviviridae viruses
10/29/2013CA2563038C Neurologically-active compounds
10/29/2013CA2562965C Nucleoside derivatives and therapeutic use thereof
10/24/2013WO2013157540A1 Nitrogen-containing heterocyclic compound or salt thereof
10/24/2013WO2013156835A1 An improved process for the preparation of erlotinib hydrochloride form a
10/24/2013WO2013119916A3 Compounds for treating spinal muscular atrophy
10/24/2013US20130281694 Method for preparing rosuvastatin salts
10/24/2013US20130281473 Substituted isoquinolinones and quinazolinones
10/24/2013US20130281448 Small molecule compounds for targeting inflammatory conditions
10/24/2013US20130281429 2,4-diamino-pyrimidines as aurora inhibitors
10/24/2013US20130281399 Treatment of diseases by epigenetic regulation
10/24/2013US20130281398 Treatment of diseases by epigenetic regulation
10/24/2013US20130281366 Heterocyclic compounds suitable for the treatment of dyslipidemia
10/23/2013EP2651930A1 Biarylamide inhibitors of leukotriene production
10/23/2013EP2651904A1 Bispyrimidines for electronic applications
10/23/2013EP2651900A1 Neprilysin inhibitors
10/23/2013EP2651896A1 Neprilysin inhibitors
10/23/2013CN103360369A Erlotinib, and preparation method of new intermediate of erlotinib
10/23/2013CN103360342A 3-Cyanoaniline alkyl aryl piperazine derivative and application in preparing medicaments
10/23/2013CN103360326A Method for refining Gefinitib crystal form I
10/23/2013CN103360325A Preparation method of erlotinib hydrochloride crystal form A
10/23/2013CN103360324A Novel pyrimidine derivatives and their use in perfume compositions
10/23/2013CN103360305A Substituted aryl piperazine aralkyl ketone derivative and application of derivative in preparing analgesic
10/23/2013CN103356636A Theramutein调节剂 Theramutein moderator
10/23/2013CN102660017B High-refractivity polyarylenesulfidesulfonamide and preparation method thereof
10/22/2013US8563736 Amide derivatives, process for preparation thereof and use thereof as insecticide
10/22/2013US8563719 Process and intermediates for preparing lapatinib
10/22/2013US8563715 Pyrimidine derivative having cell protecting effect and uses thereof
10/22/2013US8563714 Bridged spiro [2.4] heptane derivatives as ALX receptor and/or FPRL2 agonists
10/22/2013US8563594 S1P3 receptor inhibitors for treating pain
10/22/2013US8563568 Besylate salt of a BTK inhibitor
10/22/2013US8563559 Pinane-substituted pyrimidinediamine derivatives useful as Axl inhibitors
10/22/2013US8563558 Substituted pyridine urea compounds
10/22/2013US8563557 Pyrimidine derivatives and their pharmaceutical use
10/22/2013US8563539 Aminopyrimidine kinase inhibitors
10/22/2013US8563512 Neprilysin inhibitors
10/22/2013CA2611927C Process for the preparation of dihydroquinazolines
10/22/2013CA2587545C Novel compounds that modulate ppar.gamma. type receptors, and use thereof in cosmetic or pharmaceutical compositions
10/22/2013CA2580150C Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses
10/17/2013WO2013154870A1 Histone deacetylases (hdacs) inhibitors
10/17/2013WO2013153162A1 Polymorph of rilpivirine hydrochloride
10/17/2013WO2013153161A2 Novel polymorph of rilpivirine hydrochloride
10/17/2013US20130274277 Treatment for discoid lupus
10/17/2013US20130274275 4-phenylamino-quinazolin-6-yl-amides
10/17/2013US20130274263 Tubulin inhibitors
10/17/2013US20130274252 Quinazoline derivatives as kinase inhibitors
10/16/2013EP2650286A1 Quinazoline derivatives and therapeutic use thereof
10/16/2013EP2650285A1 Fungicide
10/16/2013EP2650274A2 A thionation process and a thionating agent
10/16/2013EP2649053A1 Pyrimidinone compounds for use in the treatment of diseases or conditions mediated by lp - pla2
10/16/2013EP2649050A1 Compounds
10/16/2013CN103351390A Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disorders
10/16/2013CN103351348A Synthetic method for 2-methylamino pyrimidine hydrochloride
10/16/2013CN102304095B Preparation method of sulfadoxine
10/16/2013CN102093285B Cyclic amide derivatives, and their production and use as antithrombotic agents
10/16/2013CN101790519B 6-amino-pyrimidine-4-carboxamide derivatives and related compounds which bind to the sphingosine 1-phosphate (s1p) receptor for the treatment of multiple sclerosis
10/16/2013CN101679307B Co-crystals of cyprodinil and pyrimethanil
1 ... 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 ... 427